PULSE BIOSCIENCES, INC. Logo

PULSE BIOSCIENCES, INC.

Developing nsPFA bioelectric tech for precise, non-thermal tissue ablation in cardiology.

PLSE | NDAQ

Overview

Corporate Details

ISIN(s):
US74587B1017
LEI:
Country:
United States of America
Address:
3957 POINT EDEN WAY, 94545 HAYWARD
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Pulse Biosciences, Inc. is a bioelectric medicine company developing a proprietary therapeutic platform based on Nanosecond Pulsed Field Ablation (nsPFA) technology. This novel, nonthermal energy modality is designed to precisely ablate cellular tissue while sparing adjacent noncellular structures. The company's primary focus is on advancing treatments in cardiology, particularly for atrial fibrillation, through its investigational CellFX® nsPFA™ 360 Cardiac Catheter and Cardiac Clamp. Pulse Biosciences is also expanding its nsPFA technology into other medical applications, including the development of a percutaneous electrode for the treatment of benign thyroid nodules. The company is actively advancing its product pipeline through clinical studies and regulatory submissions to establish nsPFA as a new standard of care in various medical procedures.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all PULSE BIOSCIENCES, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PULSE BIOSCIENCES, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PULSE BIOSCIENCES, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NEPHROS INC Logo
Develops high-performance water filters for pathogen control in medical & commercial markets.
United States of America NEPH
Neuraxis, INC Logo
Develops FDA-cleared, drug-free neuromodulation devices for gut-brain disorders.
United States of America NRXS
NeuroPace Inc Logo
Provides an implantable neurostimulation system to prevent seizures in drug-resistant epilepsy.
United States of America NPCE
Nexalin Technology, Inc. Logo
Develops non-invasive neurostimulation devices for drug-free mental health treatment.
United States of America NXL
NEXTBIOMEDICAL Co., Ltd. Logo
Develops polymer-based drug-device solutions for hemostasis and drug delivery worldwide.
South Korea 389650
Manufacturer of industrial pumps, aerospace parts, and blood purification medical devices.
Japan 6376
NIOX GROUP PLC Logo
Develops point-of-care devices for FeNO testing to help manage asthma and airway inflammation.
United Kingdom NIOX
NIPRO CORPORATION Logo
Global manufacturer of renal care devices, injectable drugs, and pharmaceutical packaging.
Japan 8086
Israel NISA
Noble M&B Co., Ltd. Logo
Manufactures precision optics for auto/projectors and develops biotech diagnostic products.
South Korea 106520

Talk to a Data Expert

Have a question? We'll get back to you promptly.